Paragraph 5
Government documents obtained by ProPublica show a stark rift between trade and health officials over international efforts to regulate toddler milk. The records provide a rare, candid glimpse into U.S. policymaking around children's health.
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every week.
Over the past decade, countries around the world have sought to limit the advertising of “toddler formula,” a powdered drink that often promises to improve children’s brains, immunity and eyesight.
Public health experts and advocates have backed the proposed restrictions, saying that the marketing of toddler milk can mislead parents about its health benefits and even convince some to choose formula over breastfeeding. The concerns echo those made about infant formula marketing, which many countries have banned for years.
Industry sales, however, have not only persisted but boomed — with the help of a powerful ally: the United States government. As ProPublica reported this week, federal trade agencies have worked in tandem with formula companies to fight restrictions on formula marketing in international forums while also pressuring individual countries to water down or strike their own laws.
While these battles typically play out behind the scenes, ProPublica obtained thousands of pages of government records that provide a rare window into one of the more consequential campaigns of recent years. It happened during the Obama administration in 2016, as member nations of the World Health Organization (known collectively as the World Health Assembly) considered a resolution encouraging limits on the marketing and promotion of foods aimed at infants and young children, including toddler formula.
Concerned that the measure would inspire new laws against formula marketing, the industry spent millions lobbying various U.S. agencies to intervene.
Documents obtained via a Freedom of Information Act request show a stark pattern: representatives of U.S. trade agencies aggressively sought to weaken the WHO resolution while officials from the health agencies scrambled to defend the measure. One Microsoft Word document cataloged dozens of comments and objections.
This visualization captures four of the divisions between the Office of the U.S. Trade Representative, which advises the president on trade, and federal health entities such as the Department of Health and Human Services and the Centers for Disease Control and Prevention.
The full document, including the tracked changes and comments depicted below, can be viewed here.
Arguing Over Science
A Debate Over Endorsement
Watering Down the Resolution
A Fight Over Guidance
Paragraph 5
The conflict began with squabbling over this introductory paragraph to the draft resolution that acknowledged that promotion of infant formulas can lead to decreased breastfeeding.
Jennifer Stradtman, from the U.S. trade representative's office, suggested a “more positive” framing and inserted new language.
Then, Stradtman removed the language about breastfeeding, writing in a comment that there was no evidence that the promotion of formula had been associated with stopping breastfeeding early.
Jennifer Seymour from the CDC disputed Stradtman's claims and commented that the language about breastfeeding should not be deleted.
A Health and Human Services official agreed with Seymour, arguing there was significant evidence to support the statement.
Paragraph 10
Jennifer Stradtman
Office of the United States Trade Representative
We cannot support “endorses,” “welcomes” or other positive language.
Health Agency Official
The guidance is on promotion, not setting feeding recommendations, so this insertion is oddly-placed.
Another paragraph in the draft resolution, which sought to show support for the content of the WHO’s guidance on formula, created controversy.
Stradtman, the trade official, removed the word “endorses,” commenting that the trade representative's office does not support using positive language to describe the nations' stance on the resolution.
Then, a trade official tacked on language in support of milk products.
In response, health officials questioned why the clause supporting milk products was necessary.
Paragraphs 11-12
Jennifer Stradtman
Office of the United States Trade Representative
Strong preference.
Jennifer Stradtman
Office of the United States Trade Representative
It is the view of USDA, USTR and Commerce that the terms “implement,” ... indicate to Members that the document should be adopted directly.
Jennifer Seymour
Centers for Disease Control and Prevention
Again, this is just denying the Guidance and suggesting that people should use anything else but it to determine what to do.
A paragraph in the draft resolution urging member states to implement the WHO's guidance brought more debate.
First, Stradtman asked to soften the language
Then, the trade representative's office proposed deleting the entire section, saying the language sounded too much like a directive instead of a recommendation.
Next, trade officials proposed an alternative sentence that encouraged member states to “consider a range of factors” instead of “take all necessary measures.”
The health agencies responded that the trade officials' edits were undercutting the purpose of the resolution.
Paragraph 20
Jennifer Stradtman
Office of the United States Trade Representative
This construction provides concrete guidance to the private sector on what they should be doing to end inappropriate promotion.
Jennifer Seymour
Centers for Disease Control and Prevention
NO. This change makes no sense and is completely changing the meaning of this section of the document. Once again it removes any reference to the Guidance which makes no sense for a resolution about the guidance.
Another section of the draft proposal described what the World Health Assembly was ultimately asking formula companies to do.
Trade officials struck much of the section and replaced it with instructions only about product labeling.
Seymour from the CDC fervently opposed changes by the trade representative's office.
Ultimately, the U.S. delegation and its allies persuaded the WHO nations to scrap “endorsing” the resolution, as trade officials had advocated. Instead, the body voted to “welcome” the guidance “with appreciation.”
“That has caused a lot of confusion,” said Laurence Grummer-Strawn, a WHO official who focuses on child feeding and former nutrition chief for the CDC. “What does that really mean?”
Some of the points the U.S. health agencies had fought hardest for were missing, too, including the well-documented link between formula promotion and the early cessation of breastfeeding.
U.S. trade officials soon took up the formula industry’s cause around the globe, including in Southeast Asia, where Thailand, Hong Kong and Indonesia all either watered down or put on hold new regulations after U.S. objections.
Neither Stradtman nor Michael Froman, who was the U.S. trade representative at the time, responded to requests for comment for this story.
A trade representative’s office spokesperson declined to comment on its actions around the WHO resolution. In a general statement, the spokesperson said that “with regard to infant formula, USTR, in conjunction with others in the interagency, work to uphold and advocate for policy and regulatory decisions that are based on science.”
A CDC spokesperson did not comment on the interagency debate, saying only that Seymour was invited to join as an expert on breastfeeding and infant nutrition.
The Department of Health and Human Services did not respond to questions for this story. But Jimmy Kolker, the assistant secretary who led the negotiations for the U.S. in Geneva, told Reuters at the time that he was content with the outcome.
“In any resolution,” he said, “there are trade-offs.”
Read More:
How the U.S. Waged a Global Campaign Against Baby Formula Regulation
Records and interviews show that the U.S. government repeatedly used its muscle to advance the interests of large baby formula companies while thwarting the efforts of Thailand and other developing countries to safeguard children's health.
Heather Vogell is a reporter at ProPublica.
Lucas Waldron is a graphics editor at ProPublica.
Additional design by Zisiga Mukulu.
Jennifer Stradtman
Office of the United States Trade Representative
It would be preferable to frame this guidance and its purpose in a positive manner.
Jennifer Stradtman
Office of the United States Trade Representative
We did not see any evidence in the studies on this conclusion.
Jennifer Seymour
Centers for Disease Control and Prevention
MUST NOT DELETE. There is significant evidence to support this assertion.
Office of Global Affairs
Department of Health and Human Services
MUST RETAIN. Significant evidence in the overall literature support this statement, domestically and internationally.